reSee.it Video Transcript AI Summary
Shamsu, a victim of a failed drug trial by Pfizer in Nigeria, undergoes a DNA test to prove his eligibility for compensation. Pfizer tested a drug called TROVEN on 200 children, resulting in 11 deaths and numerous injuries. While Pfizer agreed to pay $75 million in compensation, they now require DNA testing to qualify for the payment. Survivors and their families believe this is a tactic to deny them compensation, as they have already provided documents proving their involvement in the trial. Pfizer claims the DNA test is to prevent fraudulent claims. However, many victims, who are poor and illiterate, fear being used as guinea pigs in a new drug trial. Some have even abandoned their claims. Pfizer has used some of the compensation money to build a medical research center, hoping to empower locals to handle disease outbreaks themselves. This may help heal the wounds of Pfizer's experiment and benefit survivors who are too afraid to undergo DNA testing.